throbber
THE IMMUNE SYSTEM
`
`Peter Parham
`
`Stanford University
`
`The Immune System is derived from
`lmmunobio/ogy by Charles A. Janeway, Jr., Paul
`Travers and Mark Walport; also published by
`Garland Publishing and Current Trends.
`
`Garland Publishing
`New York and London
`
`CURRENT
`TRENDS
`
`Current Trends
`London
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 1
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`© 2000 by Garland Publishing/Elsevier Science Ltd.
`
`All rights reserved. No part of this publication may be reproduced, stored in a
`retrieval system or transmitted in any form or by any means-electronic,
`mechanical, photocopying, recording, or otherwise-without the prior written
`permission of the copyright holders.
`
`Distributors:
`
`Inside North America: Garland Publishing, a member of the Taylor & Francis
`Group, 29West 35th Street, New York, NY 10001-2299, US.
`Outside North America: Garland Publishing, a member of the Taylor & Francis
`Group, 11, New Fetter Lane, London EC4P 4EE, UK.
`
`ISBN: 0 8153 3043 X
`ISBN: 0 8153 3848 1
`
`(paperback) Garland
`(paperback) International Student Edition
`
`A catalog record for this book is available from the British Library.
`
`Library of Congress Cataloging-in-Publication Data
`
`Parham, Peter, 1950-
`The immune system I Peter Parham
`p.cm.
`
`Includes index.
`ISBN 0-8153-3043-X (pbk.)
`1. Immune system.
`2. Immunopathology.
`
`I. Title.
`
`QR181 .P335 2000
`616.07'9 21--dc21
`
`99-042006
`
`This book was produced using QuarkXpress 4.0 and Adobe Illustrator 7.0.
`
`Printed in United States of America.
`
`Published by Current Trends, part of Elsevier Science London, 84 Theo balds
`Road, London, WClX BRR, UK and Garland Publishing, a member of the
`Taylor & Francis Group, 29 West 35th Street, New York, NY 10001-2299, US.
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 2
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`Elements of the Immune
`System and their
`Roles in Defense
`
`Immunology is the study of the physiological mechanisms that humans and other
`animals use to defend their bodies from invasion by other organisms. The origins
`of the subject lie in the practice of medicine and in historical observations that
`people who survived the ravages of epidemic disease were untouched when faced
`with that same disease again-they had become immune to infection. Infectious
`diseases are caused by microorganisms, which have the advantage of reproducing
`and evolving much more rapidly than do their human hosts. During the course of
`an infection, the microorganism can pit enormous populations of its species
`against an individual Homo sapiens. In response, the human body invests heavily
`in cells dedicated to defense, which collectively form the immune system.
`
`The immune system is crucial to human survival. In the absence of a working
`immune system, even minor infections can take hold and prove fatal. Without
`intensive treatment, children born without a functional immune system die in
`early childhood from the effects of common infections. However, in spite of their
`immune systems, all humans suffer from infectious disease, especially when
`young. This is because the immune system takes time to build up a strong
`response to an invading microorganism, time during which the invader can mul(cid:173)
`tiply and cause disease. To provide protective immunity for the future, the
`immune system must first do battle with the microorganism. This places people
`at highest risk during their first infection with a microorganism and, in the
`absence of modern medicine, leads to substantial child mortality as witnessed in
`the developing world. When entire populations face a completely new infection,
`the outcome can be catastrophic, as experienced by indigenous Americans whose
`populations were decimated by European diseases to which they were suddenly
`exposed after 1492.
`
`In medicine the greatest triumph of immunology has been vaccination, or
`immunization, a procedure whereby severe disease is prevented by prior exposure
`to the infectious agent in a form that cannot cause disease. Vaccination provides
`the opportunity for the immune system to gain the experience needed to make a
`protective response with little risk to health or life. Vaccination was first used
`against smallpox, a viral scourge that once ravaged populations and disfigured the
`survivors. In Asia, small amounts of smallpox virus had been used to induce pro(cid:173)
`tective immunity for hundreds of years before 1721, when Lady Mary Wortley
`Montagu introduced the method into western Europe. Subsequently, in 1796,
`Edward Jenner, a doctor in rural England, showed how inoculation with cowpox
`virus offered protection against the related smallpox virus with less risk than the
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 3
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`2
`
`Chapter 1: Elements of the Immune System and their Roles in Defense
`
`earlier methods. Jenner called his procedure vaccination, after vaccinia, the name
`given to the mild disease produced by cowpox, and he is generally credited with
`its invention. Since his time, vaccination dramatically reduced the incidence of
`smallpox worldwide with the last cases being seen by physicians in the 1970s
`(Figure 1.1).
`
`Number 30
`of
`countries
`with one or
`more cases
`permonth 15
`
`smallpox
`officially
`eradicated
`
`o-i-.-....-.-..-........ -.-........ ...,.....,,.........,.....~
`1980
`1965
`1970
`1975
`Year
`
`Figure 1.1 The eradication of
`smallpox by vaccination. In 1979,
`after 3 years in which no case of
`smallpox was recorded, the World
`Health Organization announced that
`the virus had been eradicated. Since
`then there has been debate as to
`whether all laboratory stocks of the
`virus should be destroyed. One view is
`that the stocks could be used for
`nefarious purposes and should therefore
`be destroyed. The other view is that the
`virus might not have been eradicated
`and that if the disease returns, well
`characterized laboratory stocks will be
`required to renew study of the disease
`and its prevention.
`
`Effective vaccines have been made from only a fraction of the agents that cause
`disease and of those some are of limited availability because of their cost. Most of
`the widely used vaccines were first developed many years ago by processes of
`trial and error, before very much was known about the workings of the immune
`system. That approach is no longer so successful for making new vaccines, perhaps
`because all the easily won vaccines have been obtained. But deeper understand(cid:173)
`ing of the mechanisms of immunity is spawning new ideas for vaccines against
`infectious diseases and even against other types of disease such as cancer. Much
`is now known about the molecular and cellular components of the immune system
`and what they can do in the laboratory. Current research aims at understanding
`their contributions to fighting infections in the world at large. The new knowl(cid:173)
`edge is also being used to find better ways of manipulating the immune system
`to prevent the unwanted immune responses that cause allergies, autoimmune
`diseases, and rejection of organ transplants.
`
`In the first part of this chapter we consider the microorganisms that infect human
`beings and the defenses they must overcome to start an infection. These include
`physical barriers, chemical barriers, and the fixed defenses of innate immunity
`that are ready and waiting to halt infections before they can barely start. Also
`described are the individual cells and tissues of the immune system and how
`they integrate their functions with the rest of the human body. The second part
`of the chapter focuses on the more flexible and forceful defenses of adaptive
`immunity. These mechanisms are only brought into play if and when an infection
`is established. The adaptive response is always targeted to the specific problem at
`hand and is made and refined during the course of the infection. When success(cid:173)
`ful, it clears the infection and provides long-lasting immunity that prevents its
`recurrence.
`
`Defenses facing invading pathogens
`
`The purpose of the vertebrate immune system is to recognize invading foreign
`organisms, to prevent their spread, and ultimately to clear them from the body. It
`consists of billions of cells of various types, which interact with the infectious
`agent and with each other to fight the infection. With very few exceptions, the cells
`of the immune system derive originally from the bone marrow, but at some time
`in their life they leave that site to circulate in the blood, to enter other tissues, and
`to form part of specialized lymphoid tissues. This part of the chapter introduces
`the cells and tissues of the immune system and some of the molecules through
`which they carry out their functions. But first we shall consider the organisms and
`infections that the immune system evolved to protect us against.
`
`1-1 Pathogens are infectious organisms that cause disease
`
`Numerous species of microorganism colonize the human body in large numbers
`and rarely produce symptoms of disease, for example the benign strains
`of the bacterium Escherichia coli that normally inhabit the gastrointestinal tract.
`However, for some microorganisms, such as the influenza virus or the typhoid
`bacillus, infection habitually causes a disease. Any organism with the potential to
`cause disease is known as a pathogen. This definition includes not only microor(cid:173)
`ganisms that generally cause disease if they enter the body, but also ones that can
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 4
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`Defenses facing invading pathogens
`
`3
`
`Figure 1.2 The four kinds of
`pathogen that cause human disease.
`Examples of the types of pathogen are
`listed, along with the diseases they
`cause.
`
`The immune system protects against four classes of pathogen
`
`Type of pathogen
`
`Examples
`
`Bacteria
`
`Viruses
`
`Fungi
`
`Parasites
`
`Salmonella enteritidis
`Mycobacterium tuberculosis
`
`Variola
`Influenza
`HIV
`
`Epidermophyton floccosum
`Candida albicans
`
`I
`
`I
`
`11
`
`11
`
`Diseases
`
`Food poisoning
`Tuberculosis
`
`Smallpox
`Flu
`AIDS
`
`Ringworm
`Thrush, systemic candidiasis
`
`protozoa
`
`worms
`
`Trypanosoma brucei
`Leishmania donovani
`Plasmodium falciparum
`Ascaris lumbricoides
`Schistosoma mansoni
`
`Sleeping sickness
`Leishmaniasis
`Malaria
`Ascariasis
`Schistosomiasis
`
`colonize the human body to no ill effect for much of the time but cause illness if
`the body's defenses are weakened or if the organism gets into the 'wrong' place.
`The latter kinds of microorganism are known as opportunistic pathogens.
`
`Pathogens can be divided into four kinds: bacteria, viruses, and fungi, which are
`each a group of related microorganisms, and internal parasites, a less precise
`term used to embrace a heterogeneous collection of unicellular protozoa and
`multicellular invertebrates, mainly worms (Figure 1.2). In this book we consider
`the functions of the human immune system principally in the context of control(cid:173)
`ling infections. For some pathogens, this necessitates their complete elimination,
`but for others it is sufficient to limit the size and location of the pathogen popula(cid:173)
`tion within the host. Figure 1.3 gives examples of pathogens from the four classes.
`
`Over evolutionary time, the relationship between a pathogen and its human hosts
`can change, affecting the severity of the disease produced. Most pathogenic
`organisms have evolved special adaptations that enable them to invade their
`hosts, replicate in them and be transmitted. However, the rapid death of its host is
`rarely in a microbe's interest, because this destroys both its home and its source of
`food. Consequently, those organisms with the potential to cause severe and rapidly
`fatal disease often tend to evolve towards an accommodation with their hosts. In
`complementary fashion, host populations have evolved a degree of in-built
`genetic resistance to common disease-causing organisms, as well as acquiring
`lifetime immunity to endemic diseases as a result of infection in childhood.
`Because of the interplay between host and pathogen, the nature and severity of
`infectious diseases in the human population are always changing.
`
`Influenza is a good example of a common viral disease that, although severe in its
`symptoms, is usually overcome successfully by the immune system. The fever,
`aches, and lassitude that accompany infection can be overwhelming, and it is dif(cid:173)
`ficult to imagine overcoming foes or predators at the peak of a bout of influenza.
`However, despite the severity of the symptoms, most strains of influenza do not
`pose any great danger to healthy people in populations in which influenza is
`endemic. Warm, well-nourished, and otherwise healthy individuals usually
`recover in a couple of weeks and take it for granted that their immune systems will
`accomplish this task. Pathogens new to the human population, in contrast, often
`cause high mortality-between 60% and 75% in the case, of the Ebola virus.
`
`I
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 5
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`4
`
`Chapter 1: Elements of the Immune System and their Roles in Defense
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 6
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`Defenses facing invading pathogens
`
`5
`
`Figure 1.3 (opposite) The diversity of human pathogens. Panel
`a: light micrograph of Schistosoma mansoni, the helminth worm that
`causes schistosomiasis. The adult intestinal blood fluke form is shown:
`the male is thick and bluish, the female white and thread-like.
`Magnification x 5. Panel b: false-color scanning electron micrograph
`of red blood cells and Trypanosoma brucei, a protozoan of the type
`that causes African sleeping sickness. Magnification x 1750.
`Panel c: false-color scanning electron micrograph of Pneumocystis
`carinii, the fungus that causes opportunistic infections in patients
`whose immune system is suppressed by disease or drugs. The view is
`of a lung alveolus from a monkey who is immunosuppressed because
`of infection with a simian virus that causes an acquired
`immune deficiency syndrome (AIDS). The fungal cells have been
`colored green. Magnification x 720. Panel d: scanning electron
`micrograph of Epidermophyton floccosum, the dermatophyte fungus
`that causes ringworm. Pear-shaped spore-producing structures
`(macronidia) are seen connected by filaments (hyphae). Magnification
`x 500. Panel e: false-color transmission electron micrograph of
`human immunodeficiency virus (HIV), the cause of AIDS.
`Magnification x 80,000. Panel f: false-color transmission electron
`micrograph of influenza virus, an orthomyxovirus that causes
`influenza. Magnification x 40,000. Panel g: false-color scanning
`electron micrograph of the fungus Candida albicans, a normal
`inhabitant of the human body that occasionally causes thrush and
`more severe systemic infections. Pseudohyphae are visible in a row.
`At the junctions of the hyphae, rounded yeast-like cells (blastospores)
`are budded off into colonies. Magnification x 1400. Panel h:
`false-color scanning electron micrograph of Staphylococcus aureus, a
`Gram-positive bacterium that colonizes human skin and is the
`common cause of pimples and boils. Some strains, however, cause
`food poisoning. The small spherical cells (cocci) typically form
`grape-like clusters. Magnification x 5000. Panel i: false-color scanning
`electron micrograph of Mycobacterium tuberculosis, the bacterium
`that causes tuberculosis. Magnification x 15,000. Panel j: false-color
`transmission electron micrograph of a human cell (colored green) and
`bacteria of the species Listeria monocytogenes, a Gram-positive
`coccobacillus that can contaminate processed food, causing disease
`(listeriosis) in immunocompromised individuals and pregnant women.
`Magnification x 1250. Panel k: false-color scanning electron
`micrograph of Salmonella enteritidis, a Gram-negative, rod-shaped
`bacterium that is a common cause of food poisoning. The hair-like
`flagella enable the bacteria to move. Magnification x 6500.
`Panel I: false-color scanning electron micrograph of Streptococcus
`pyogenes, a Gram-positive bacterium that is the principal cause of
`tonsilitis and scarlet fever, and can also cause ear infections. It has
`rounded or spherical cells that sometimes form chains as seen here.
`Magnification x 6500.
`
`1-2 The skin and mucosa! surfaces form physical barriers
`against infection
`
`The skin is the human body's first defense against infection. It forms a tough
`impenetrable barrier of epithelium protected by layers of keratinized cells. This
`barrier can be breached by physical damage, such as wounds, burns, or surgical
`procedures, which exposes soft tissues and renders them vulnerable to infection.
`Until the adoption of antiseptic procedures in the nineteenth century, surgery
`was a very risky business, principally because of the life-threatening infections
`that the procedures introduced. For the same reason, far more soldiers have died
`from infection acquired on the battlefield than from the direct effects of enemy
`action. Ironically, the need to conduct increasingly sophisticated and wide(cid:173)
`ranging warfare has been the major force driving improvements in surgery and
`medicine. As an example from immunology, the burns suffered by fighter pilots
`during World War II stimulated studies on skin transplantation that led directly to
`the understanding of the cellular basis of the immune respo{se.
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 7
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`6
`
`Chapter 1: Elements of the Immune System and their Roles in Defense
`
`r
`
`I
`
`skin
`
`nails
`
`~----eyes
`
`'il>i-----oral
`cavity
`
`respiratory tract
`
`I
`mammary -l------tt--""I::.
`\
`glands
`<+ - - - - - - - esophagus
`. - - ->T - - - - - stomach
`
`gastrointestinal tract
`
`kidneys}
`urogenital tract
`
`MH•'-------+-+-i- bla~der
`,.,._ __ ~--+- vagina
`
`;
`\
`\
`
`Figure 1.4 The physical barriers that
`separate the body from its external
`environment. In these images of a
`woman, the strong barriers to infection
`provided by the skin, hair, and nails are
`colored blue and the more vulnerable
`mucosa! membranes are colored red.
`
`Continuous with the skin are the epithelia lining the respiratory, gastrointestinal,
`and urogenital tracts (Figure 1.4). On these internal surfaces, the impermeable
`skin gives way to tissues that are specialized for communication with their envi(cid:173)
`ronment and are more vulnerable to microbial invasion. Such surfaces are known
`as mucosa! surfaces or mucosa as they are continually bathed in the mucus that
`they secrete. This thick fluid layer contains glycoproteins, proteoglycans, and
`enzymes that protect the epithelial cells from damage and help to limit infection.
`The enzyme lysozyme in tears and saliva is one of a number of anti-bacterial sub(cid:173)
`stances in secretions from mucosal surfaces. In the respiratory tract, mucus is
`continuously removed through the action of epithelial cells bearing beating cilia
`and is replenished by mucus-secreting goblet cells. The respiratory mucosa are
`thus continually cleansed of unwanted material, including infectious microor(cid:173)
`ganisms that have been breathed in. Microorganisms are also deterred by the
`acidic environments of the stomach, the vagina, and the skin. With such defenses,
`skin and mucosa provide a well-maintained physical and chemical barrier that
`prevents most pathogens from gaining access to the cells and tissues of the body.
`When that barrier is breached and pathogens gain entry to the body's soft tissues,
`the defenses of the immune system are brought into play.
`
`1-3 Immune defenses consist of innate and adaptive immunity
`
`The body has two types of response to invasion by a pathogen-the innate
`immune response, or innate immunity, and the adaptive immune response.
`The mechanisms of innate immunity come into play first. They are always pre(cid:173)
`sent and can rapidly be brought into action, but do not always have the power to
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 8
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`Defenses facing invading pathogens
`
`7
`
`'·iure L'j The principal
`characteristics of innate and
`adaptive immunity.
`
`Recognition mechanisms of innate immunity
`
`Recognition mechanisms of adaptive immunity
`
`I Rapid response (hours)
`I Invariant
`I Limited number of specificities
`I Constant during response
`\_
`
`I Slow response (days to weeks)
`I
`I I Variable
`I I Numerous highly selective specificities
`I I Improve during response
`)
`
`~
`
`,,.l L,
`
`I
`I
`I
`I
`
`Common effector mechanisms for the destruction of pathogens
`
`eliminate the infection. In such circumstances the innate immune response
`contains the infection while the more powerful forces of the adaptive immune
`response are martialled.
`
`Innate immunity uses general molecular recognition mechanisms to detect the
`presence of bacteria and viruses, and it does not lead to long-term immunity to
`that particular pathogen. The adaptive immune response, in contrast, focuses
`specifically on the pathogen at hand and leads to a condition of long-lived pro(cid:173)
`tection called adaptive immunity to that pathogen alone, and no other. Infection
`with the measles virus, for example, results in immunity to measles but not to
`mumps, an infection caused by a different virus. However, although the recogni(cid:173)
`tion mechanisms of innate and adaptive immune responses differ, the means
`used to destroy pathogens after their identification are common to both (Figure
`1.5). Innate immune defenses are present in vertebrates and invertebrates, but
`nnly vertebrates seem to have evolved adaptive immune responses.
`
`The immune system recognizes the presence of a pathogen by the use of so-called
`'recognition molecules'. These are proteins that bind to molecules produced by
`the pathogen or carried on its surface. Some recognition molecules are free in the
`circulation; others are receptor proteins present on cells of the immune system.
`Only a few types of recognition molecule are involved in innate immunity; in gen(cid:173)
`eral, these recognize and distinguish between the major categories of pathogens
`by binding to distinctive shared features on the pathogen surface. These recogni(cid:173)
`tion molecules are always present and can therefore initiate an immediate and
`;-apid response to an invader. In contrast, adaptive immunity has millions of dif(cid:173)
`!'erent recognition proteins at its disposal, but requires time for the most useful
`•Jnes to be selected and mass-produced for use against the particular pathogen.
`
`,i White blood cells are responsible for immune responses
`
`f'he cells responsible for both innate and adaptive immune responses are princi(cid:173)
`pally the white blood cells or leukocytes, and the tissue Lells related to them
`'·Figure 1.6). They all originate in the bone marrow, from where they migrate to
`Jevelop further and perform their functions. Cells of the immune system are
`:)resent throughout the body. Some are resident within tissues, where they
`espond to local trauma and sound the alarm; others circulate in body fluids,
`>ram where they are recruited to sites of infection. In defending the body against
`•Jathogens, white blood cells cooperate with each other first to recognize the
`·nicroorganism as an invader and then to destroy it.
`
`i:"he lymphocytes provide cells of both innate and adaptive immunity. Small
`ymphocytes are the cells responsible for adaptive immune responses and carry
`he recognition molecules of adaptive immunity on their surface. Recognition of
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 9
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`8
`
`Chapter 1: Elements of the Immune System and their Roles in Defense
`
`Small lymphocyte
`
`Eosinophil
`
`Production of antibodies (B cells) or cytotoxic
`and helper functions (T cells)
`
`Killing of antibody-coated parasites through release
`of granule contents
`
`Plasma cell
`
`Basophil
`
`b
`
`Fully differentiated form of B cell that secretes antibodies
`
`g
`
`Unknown
`
`Natural killer cell
`
`Mast cell
`
`c
`
`Kills cells infected with certain viruses
`
`h
`Expulsion of parasites from body through release of granules
`containing histamine and other active agents
`
`Dendritic cell
`
`Monocyte
`
`Activation of T cells and initiation of adaptive
`immune responses
`
`Circulating precursor cell to macrophage
`
`Neutrophil
`
`e
`
`Phagocytosis and killing of microorganisms
`
`Macrophage
`
`@ 0
`
`0
`
`Phagocytosis and killing of microorganisms.
`Activation of T cells and initiation of immune responses
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 10
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`Defenses facing invading pathogens
`
`9
`
`:1ure 1.5 (opposite) Types of white blood cell. The different
`types of white blood cell are depicted in schematic diagrams, which
`indicate their characteristic morphological features, and in accompa(cid:173)
`nying light micrographs. Their main functions are indicated. Red
`blood cells are also seen in most of the pictures. They are smaller than
`the white blood cells and have no nucleus. Photographs courtesy of
`N. Rooney (a, d, e, f, g, j) and D. Friend (b, c, h, i).
`
`1 pathogen by small lymphocytes drives a process of lymphocyte selection and
`iifferentiation that after 1-2 weeks produces a powerful immune response tailored
`o the invading organism.
`
`The small lymphocytes, although morphologically indistinguishable from each
`other, are divided into various classes with respect to their recognition molecules
`:ind the functions that they are programmed to perform. The most important
`:lifference is between B lymphocytes or B cells, and T lymphocytes or T cells.
`The recognition molecules of B cells are immunoglobulins carried on the B-cell
`surface; whereas those of T cells are known as T-cell receptors. On activation by
`infection, B cells divide and differentiate into plasma cells, which make antibod(cid:173)
`:es-soluble forms of immunoglobulins that are released into the blood and
`3Xtracellular fluid. T cells have more diverse functions, which they perform on
`~nreraction with other cells of the immune system and cells infected with intra(cid:173)
`·:ellular pathogens such as viruses. When activated by infection, T cells differentiate
`into effector T cells with various functions. In addition to small lymphocytes, the
`blood contains large granular lymphocytes called natural killer cells or NK cells.
`They function in innate immunity and are important in the defense against viral
`infections. In the rest of this book the term 'lymphocyte' will be used to denote the
`small lymphocytes-B cells and T cells.
`
`The principal cell that cooperates with lymphocytes to initiate adaptive immune
`,·espouses is the dendritic cell; this has a distinctive star-shaped morphology and
`'s found in many tissues as well as in the blood.
`
`The job of destroying pathogenic organisms rests largely with two types of
`;hagocytic cell, the macrophage and the neutrophil. Macrophages are widely
`distributed in tissues and they derive from circulating white blood cells called
`monocytes. Tissue macrophages are large cells characterized by an extensive
`cytoplasm with numerous vacuoles, often containing engulfed materials. They are
`che general scavenger cells of the body, phagocytosing and disposing of dead cells
`and cell debris. In both innate and adaptive immune responses, one of their roles
`is to engulf, kill, and break down microorganisms. Macrophages have mecha(cid:173)
`nisms for recognizing and reacting to pathogens, which makes them important
`cells of innate immunity. They also cooperate with lymphocytes to develop adaptive
`immune responses.
`
`The neutrophil is smaller than the macrophage and is by far the most abundant
`.vhite blood cell. Unlike the macrophage, it is not resident in healthy tissues but
`capidly migrates to sites of tissue damage, and is at the front line of innate
`:mmune defenses, where it is the principal phagocytic and microbicidal cell. Like
`•he macrophage, it possesses general pathogen-recognition mechanisms, and is
`;pecialized to engulf and kill microorganisms.
`
`iMated to the neutrophil are two other kinds of white blood cell, the eosinophil
`;md the basophil. Neutrophils, eosinophils, and basophils are collectively called
`~ranulocytes because of their prominent cytoplasmic granules, which contain
`,·eactive substances that kill microorganisms and enhance inflammation. Because
`:;ranulocytes have irregularly shaped nuclei with two to five lobes they are
`:dso called polymorphonuclear leukocytes. The eosinophil is the second most
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 11
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`1 O
`
`Chapter 1: Elements of the Immune System and their Roles in Defense
`
`abundant granulocyte in the blood and provides defense against parasites such as
`helminth worms. The least abundant granulocyte is the basophil. They are so rare
`that little is known of their contribution to the immune response. Mast cells are
`bone-marrow derived cells found in connective tissues. They contain granules
`containing substances that contribute to inflammation.
`
`1-5 The cells of the immune system derive from precursors in
`the bone marrow
`
`All the cells that circulate in the blood are derived from a common progenitor or
`precursor cell in the bone marrow. This pluripotent precursor is called the
`
`Bone marrow
`
`hematopoietic stem cell
`
`common
`lymphoid progenitor
`
`Bone marrow
`
`@
`
`myeloid
`progenitor
`
`@
`
`erythroid
`progenitor
`
`I I
`
`Blood
`
`erythroblast
`
`Polymorphonuclear leukocytes
`
`B cell
`
`T cell
`
`basophil
`
`eosinophil
`
`neutrophil
`
`I I
`I I
`I I
`I I
`
`I I @8
`
`0
`0 ~'C)
`\J
`0
`0uoG
`platelets
`
`0
`
`erythrocyte
`
`Effector cells
`
`Tissues
`
`plasma
`cell
`
`effector
`T cell
`
`NKcell
`
`~ @ 0
`
`dendritic cell
`
`mast cell
`
`macrophage
`
`Figure 1. 7 Circulating blood cells and certain tissue cells
`derive from a common hematopoietic stem cell in the
`bone marrow. The pluripotent stem cell (brown) divides and
`differentiates into more specialized progenitor cells that give
`rise to the lymphoid lineage, the myeloid lineage, and the
`erythrocyte/megakaryocyte lineage. The common lymphoid
`progenitor divides and differentiates to give B cells (yellow),
`T cells (blue), and NK cells (purple). On activation by infection,
`B cells divide and differentiate into plasma cells, whereas T cells
`
`differentiate into various types of activated effector T cell. The
`myeloid progenitor cell divides and differentiates to produce at
`least six cell types. These are: the three types of granulocyte(cid:173)
`the neutrophil, the eosinophil, and the basophil; the mast cell,
`which takes up residence in connective and mucosal tissues; the
`circulating monocyte, which gives rise to the macrophages
`resident in tissues; and the dendritic cell. The erythroid
`progenitor gives rise to erythrocytes and megakaryocytes.
`
`Luitpold Pharmaceuticals, Inc., Ex. 2008, p. 12
`Pharmacosmos A/S v. Luitpold Pharmaceuticals, Inc., IPR2015-01495
`
`

`
`hematopoietic stem cell. The developmental pathways by which blood cells are
`produced are outlined in Figure 1.7. As hematopoietic stem cells mature in the
`bone marrow they give rise to different kinds of stem cells with more limited
`developmental potential. One kind of stem cell, called the erythroid progenitor,
`gives rise to the erythroid lineage of blood cells-the oxygen-carrying red blood
`cells (erythrocytes) and the megakaryocytes. The latter remain resident in the
`bone marrow; platelets are formed from them and released into the blood. A
`second stem cell gives rise to the monocyte/macrophage lineage, dendritic cells,
`the granulocytes (neutrophils, eosinophils, and basophils), and mast cells. These
`cells are known as the myeloid lineage of white blood cells and their progenitor
`stem cell as the myeloid progenitor. The third type of stem cell is the common
`lymphoid progenitor. It gives rise to white blood cells of the lymphoid lineage,
`which are the small lymphocytes and the larger NK cells.
`
`1-6 Lymphocytes are found in specialized lymphoid tissues
`
`As well as circulating in the blood, lymphocytes congregate in specialized tissues
`known as lymphoid tissues or lymphoid

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket